Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate

NCT02885181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: GS-9876
DRUG: Filgotinib
DRUG: GS-9876 placebo
DRUG: Filgotinib placebo
DRUG: Methotrexate

Sponsor

Gilead Sciences